Biogen, Inc. (BIIB)
198.00
+4.92
(+2.55%)
USD |
NASDAQ |
May 27, 13:07
Biogen Cash from Investing (Quarterly) : -209.50M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen, Inc. | -716.00M |
| Gilead Sciences, Inc. | 1.77B |
| AbbVie, Inc. | -574.00M |
| Apellis Pharmaceuticals, Inc. (DELISTED) | 0.00 |
| Moderna, Inc. | -76.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 645.50M |
| Cash from Financing (Quarterly) | -43.80M |
| Free Cash Flow | 2.316B |
| Free Cash Flow Per Share (Quarterly) | 3.769 |
| Free Cash Flow to Equity (Quarterly) | 655.00M |
| Free Cash Flow to Firm (Quarterly) | 616.48M |
| Free Cash Flow Yield | 7.95% |